Lisette Dekker
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Lisette Dekker has a total of 32 co-authors. Here are the top co-authors by number of shared publications:
- Ingrid J. M. Han-Geurts
Department of Surgery Proctos Kliniek Bilthoven The Netherlands
6 shared publications - Justin Y. van Oostendorp
Department of Surgery Amsterdam UMC Amsterdam The Netherlands
5 shared publications - Susan van Dieren
Department of Surgery, Amsterdam UMC, location University of Amsterdam, Amsterdam, the Netherlands
5 shared publications - Wilhelmus Adrianus Bemelman
Amsterdam University Medical Center
5 shared publications I. J. M. Han-Geurts
Department of Surgery, Proctos Clinic, Bilthoven, The Netherlands
4 shared publications- Ruben Veldkamp
Department of Surgery, Proctos Kliniek, Bilthoven, The Netherlands
4 shared publications
Latest Publications
- Open Access
- 8 July 2026
- Published by Wiley in Anz Journal of Surgery
- Vol. 96 (10) , 3163-3173
Value of 3D ‐High Resolution Anorectal Manometry Before and After Fistulotomy for Simple Perianal Fistulas: A Prospective Cohort Study
Aim: Surgical treatment of perianal fistulas is challenging due to the risk of postoperative fecal incontinence, which can significantly impair quality of life. Fistulotomy is commonly used as an effective treatment for simple fistulas with limited sphincter involvement, assuming a minimal risk of continence deterioration. However, partial sphincter division may still affect anorectal pressures. This study prospectively evaluates changes in anal sphincter function using three‐dimensional high resolution anorectal manometry (3D‐HRAM) alongside continence and quality of life outcomes before and after fistulotomy. Methods: A prospective single‐center cohort study was conducted at a tertiary referral center in the Netherlands. Adults undergoing fistulotomy for simple perianal fistulas were included. Pre‐ and postoperative assessments included clinical evaluation, 3D‐endoanal ultrasound, 3D‐HRAM, and functional outcome measures for fecal incontinence and quality of life. Long‐term outcomes were assessed via standardized questionnaires at 12 months postoperatively. Primary outcomes were changes in anorectal pressures, continence deterioration, and quality of life. Results: Among 47 patients, 26% experienced continence deterioration despite unchanged mean sphincter pressures postoperatively. This subgroup showed lower preoperative fistula tract pressures and altered voluntary squeeze pressures on 3D‐HRAM. Despite this, overall quality of life improved significantly following fistula healing. Conclusion: 3D‐HRAM allows for regional pressure mapping in perianal fistula but does not reliably predict continence deterioration after fistulotomy. Given the low risk of severe incontinence, routine preoperative 3D‐HRAM is not warranted for simple fistulas. Future research should refine continence assessment and clarify its role in complex fistulas, where the risk impairment is higher. Trial Registration: Dutch trial register: NL78713.018.21
- 8 July 2026
- Published by Wiley in Anz Journal of Surgery
- Vol. 96 (10) , 3163-3173
Open AccessValue of 3D ‐High Resolution Anorectal Manometry Before and After Fistulotomy for Simple Perianal Fistulas: A Prospective Cohort Study
Aim: Surgical treatment of perianal fistulas is challenging due to the risk of postoperative fecal incontinence, which can significantly impair quality of life. Fistulotomy is commonly used as an effective treatment for simple fistulas with limited sphincter involvement, assuming a minimal risk of continence deterioration. However, partial sphincter division may still affect anorectal pressures. This study prospectively evaluates changes in anal sphincter function using three‐dimensional high resolution anorectal manometry (3D‐HRAM) alongside continence and quality of life outcomes before and after fistulotomy. Methods: A prospective single‐center cohort study was conducted at a tertiary referral center in the Netherlands. Adults undergoing fistulotomy for simple perianal fistulas were included. Pre‐ and postoperative assessments included clinical evaluation, 3D‐endoanal ultrasound, 3D‐HRAM, and functional outcome measures for fecal incontinence and quality of life. Long‐term outcomes were assessed via standardized questionnaires at 12 months postoperatively. Primary outcomes were changes in anorectal pressures, continence deterioration, and quality of life. Results: Among 47 patients, 26% experienced continence deterioration despite unchanged mean sphincter pressures postoperatively. This subgroup showed lower preoperative fistula tract pressures and altered voluntary squeeze pressures on 3D‐HRAM. Despite this, overall quality of life improved significantly following fistula healing. Conclusion: 3D‐HRAM allows for regional pressure mapping in perianal fistula but does not reliably predict continence deterioration after fistulotomy. Given the low risk of severe incontinence, routine preoperative 3D‐HRAM is not warranted for simple fistulas. Future research should refine continence assessment and clarify its role in complex fistulas, where the risk impairment is higher. Trial Registration: Dutch trial register: NL78713.018.21
- Open Access
- 10 June 2025
- Published by Wolters Kluwer Health in Diseases of the Colon & Rectum
- Vol. 68 (9) , 1100-1111
Cost-Effectiveness of Rubber Band Ligation Versus Hemorrhoidectomy for the Treatment of Grade III Hemorrhoids: Analysis Using Evidence From the HOLLAND Randomized Controlled Trial
BACKGROUND: Hemorrhoids significantly impact quality of life and health care costs. Although rubber band ligation and hemorrhoidectomy are common treatments for grade III hemorrhoids, comparative cost-effectiveness data are limited. OBJECTIVE: To assess the cost-effectiveness and cost-utility of rubber band ligation compared to hemorrhoidectomy from a societal perspective within the context of the HOLLAND trial. DESIGN: Cost-effectiveness and cost-utility analyses using data from a multicenter, randomized controlled trial. SETTINGS: Ten Dutch hospitals participating in the HOLLAND trial. PATIENTS: Adults with symptomatic grade III hemorrhoids randomly assigned to receive rubber band ligation or hemorrhoidectomy treatment. INTERVENTIONS: Rubber band ligation (up to 2 sessions) or excisional hemorrhoidectomy. MAIN OUTCOME MEASURES: Cost per quality-adjusted life year gained and cost per recurrence avoided over 24 months from a societal perspective. RESULTS: Seventy-nine patients were analyzed (33 for hemorrhoidectomy and 46 for rubber band ligation). Hemorrhoidectomy resulted in better clinical outcomes with a quality-adjusted life year difference of 0.08 (95% CI, 0.04–0.13) and a recurrence difference of 33.5% (95% CI, 15.3%–51.7%). Hospital costs were higher for hemorrhoidectomy (€1364; 95% CI, 895–1834; p < 0.001), as were societal costs (€1984; 95% CI, –132 to 4101; p = 0.066). The incremental cost-utility ratio for hemorrhoidectomy was €24,042 per quality-adjusted life year gained, and the incremental cost-effectiveness ratio was €5918 per recurrence avoided. The probability of hemorrhoidectomy being cost-effective was 45.5% at €20,000 per quality-adjusted life year and 83.9% at €50,000 per quality-adjusted life year. For recurrence avoidance, probabilities were 98.3% and 99.8%, respectively. LIMITATIONS: The small sample size may limit generalizability and the ability to detect rare but costly complications. Procedural costs were based on average hospital prices, which is a pragmatic approach but is less detailed than bottom-up costing. CONCLUSIONS: In patients with grade III hemorrhoids, hemorrhoidectomy provides better long-term clinical outcomes, including higher quality of life and lower recurrence rates compared to rubber band ligation. However, its cost-effectiveness varies depending on societal willingness-to-pay thresholds. Caution is warranted before discarding it as a first-line treatment solely based on health care costs or limited operating room availability. See Video Abstract. CLINICAL TRIAL REGISTRATION NUMBER: NCT04621695 COSTO-EFECTIVIDAD DE LA LIGADURA CON BANDA ELÁSTICA VERSUS HEMORROIDECTOMÍA PARA EL TRATAMIENTO DE HEMORROIDES DE GRADO III: ANÁLISIS UTILIZANDO EVIDENCIA DEL ENSAYO HOLLAND CONTROLADO ALEATORIZADO: ANTECEDENTES: Las hemorroides afectan significativamente la calidad de vida y los costos de atención médica. Si bien la ligadura con banda elástica y la hemorroidectomía son tratamientos comunes para las hemorroides de grado III, los datos comparativos de costo-efectividad son limitados. OBJETIVO: Evaluar el costo-efectividad y el costo-utilidad de la ligadura con banda elástica en comparación con la hemorroidectomía desde una perspectiva social en el contexto del ensayo HOLLAND. DISEÑO: Análisis de costo-efectividad y costo-utilidad utilizando datos de un ensayo controlado aleatorizado multicéntrico. ESTABLECIMIENTO: Diez hospitales holandeses participantes en el ensayo HOLLAND. PACIENTES: Adultos con hemorroides sintomáticas de grado III aleatorizados a ligadura con banda elástica o hemorroidectomía. INTERVENCIONES: Ligadura con banda elástica (hasta dos sesiones) o hemorroidectomía escisional. PRINCIPALES MEDIDAS DE VALORACIÓN: Costo por año de vida ajustado a calidad (AVAC) ganado y costo por recurrencia evitada durante 24 meses desde una perspectiva social. RESULTADOS: Se analizaron setenta y nueve pacientes (33 hemorroidectomía, 46 ligadura con banda elástica). La hemorroidectomía presentó mejores resultados clínicos, con una diferencia de AVAC de 0,08 (IC del 95 %, 0,04-0,13) y una diferencia de recurrencia del 33,5 % (IC del 95 %, 15,3 %-51,7 %). Los costes hospitalarios fueron mayores para la hemorroidectomía (1364 €; IC del 95 %, 895-1834; p < 0,001), al igual que los costes sociales (1984 €; IC del 95 %, -132-4101; p = 0,066). La razón costo-utilidad incremental para la hemorroidectomía fue de 24.042 € por AVAC ganado, y la razón costo-efectividad incremental fue de 5.918 € por recurrencia evitada. La probabilidad de que la hemorroidectomía sea costo-efectiva fue del 45,5% con 20.000 €/AVAC y del 83,9% con 50.000 €/AVAC. Para la prevención de la recurrencia, las probabilidades fueron del 98,3% y del 99,8%, respectivamente. LIMITACIONES: El pequeño tamaño de la muestra puede limitar la generalización y la capacidad de detectar complicaciones poco frecuentes pero costosas. Los costos del procedimiento se basaron en los precios hospitalarios promedio, lo cual constituye un enfoque pragmático, aunque menos detallado que el cálculo de costos ascendente. CONCLUSIONES: En pacientes con hemorroides de grado III, la hemorroidectomía ofrece mejores resultados clínicos a largo plazo, incluyendo una mayor calidad de vida y menores tasas de recurrencia en comparación con la ligadura con banda elástica. Sin embargo, su costo-efectividad varía en función de los umbrales de disposición a pagar de la sociedad. Se recomienda precaución antes de descartarla como tratamiento de primera línea basándose únicamente en los costos sanitarios o la disponibilidad limitada de quirófanos. (Traducción--Ingrid Melo)
- 10 June 2025
- Published by Wolters Kluwer Health in Diseases of the Colon & Rectum
- Vol. 68 (9) , 1100-1111
Open AccessCost-Effectiveness of Rubber Band Ligation Versus Hemorrhoidectomy for the Treatment of Grade III Hemorrhoids: Analysis Using Evidence From the HOLLAND Randomized Controlled Trial
BACKGROUND: Hemorrhoids significantly impact quality of life and health care costs. Although rubber band ligation and hemorrhoidectomy are common treatments for grade III hemorrhoids, comparative cost-effectiveness data are limited. OBJECTIVE: To assess the cost-effectiveness and cost-utility of rubber band ligation compared to hemorrhoidectomy from a societal perspective within the context of the HOLLAND trial. DESIGN: Cost-effectiveness and cost-utility analyses using data from a multicenter, randomized controlled trial. SETTINGS: Ten Dutch hospitals participating in the HOLLAND trial. PATIENTS: Adults with symptomatic grade III hemorrhoids randomly assigned to receive rubber band ligation or hemorrhoidectomy treatment. INTERVENTIONS: Rubber band ligation (up to 2 sessions) or excisional hemorrhoidectomy. MAIN OUTCOME MEASURES: Cost per quality-adjusted life year gained and cost per recurrence avoided over 24 months from a societal perspective. RESULTS: Seventy-nine patients were analyzed (33 for hemorrhoidectomy and 46 for rubber band ligation). Hemorrhoidectomy resulted in better clinical outcomes with a quality-adjusted life year difference of 0.08 (95% CI, 0.04–0.13) and a recurrence difference of 33.5% (95% CI, 15.3%–51.7%). Hospital costs were higher for hemorrhoidectomy (€1364; 95% CI, 895–1834; p < 0.001), as were societal costs (€1984; 95% CI, –132 to 4101; p = 0.066). The incremental cost-utility ratio for hemorrhoidectomy was €24,042 per quality-adjusted life year gained, and the incremental cost-effectiveness ratio was €5918 per recurrence avoided. The probability of hemorrhoidectomy being cost-effective was 45.5% at €20,000 per quality-adjusted life year and 83.9% at €50,000 per quality-adjusted life year. For recurrence avoidance, probabilities were 98.3% and 99.8%, respectively. LIMITATIONS: The small sample size may limit generalizability and the ability to detect rare but costly complications. Procedural costs were based on average hospital prices, which is a pragmatic approach but is less detailed than bottom-up costing. CONCLUSIONS: In patients with grade III hemorrhoids, hemorrhoidectomy provides better long-term clinical outcomes, including higher quality of life and lower recurrence rates compared to rubber band ligation. However, its cost-effectiveness varies depending on societal willingness-to-pay thresholds. Caution is warranted before discarding it as a first-line treatment solely based on health care costs or limited operating room availability. See Video Abstract. CLINICAL TRIAL REGISTRATION NUMBER: NCT04621695 COSTO-EFECTIVIDAD DE LA LIGADURA CON BANDA ELÁSTICA VERSUS HEMORROIDECTOMÍA PARA EL TRATAMIENTO DE HEMORROIDES DE GRADO III: ANÁLISIS UTILIZANDO EVIDENCIA DEL ENSAYO HOLLAND CONTROLADO ALEATORIZADO: ANTECEDENTES: Las hemorroides afectan significativamente la calidad de vida y los costos de atención médica. Si bien la ligadura con banda elástica y la hemorroidectomía son tratamientos comunes para las hemorroides de grado III, los datos comparativos de costo-efectividad son limitados. OBJETIVO: Evaluar el costo-efectividad y el costo-utilidad de la ligadura con banda elástica en comparación con la hemorroidectomía desde una perspectiva social en el contexto del ensayo HOLLAND. DISEÑO: Análisis de costo-efectividad y costo-utilidad utilizando datos de un ensayo controlado aleatorizado multicéntrico. ESTABLECIMIENTO: Diez hospitales holandeses participantes en el ensayo HOLLAND. PACIENTES: Adultos con hemorroides sintomáticas de grado III aleatorizados a ligadura con banda elástica o hemorroidectomía. INTERVENCIONES: Ligadura con banda elástica (hasta dos sesiones) o hemorroidectomía escisional. PRINCIPALES MEDIDAS DE VALORACIÓN: Costo por año de vida ajustado a calidad (AVAC) ganado y costo por recurrencia evitada durante 24 meses desde una perspectiva social. RESULTADOS: Se analizaron setenta y nueve pacientes (33 hemorroidectomía, 46 ligadura con banda elástica). La hemorroidectomía presentó mejores resultados clínicos, con una diferencia de AVAC de 0,08 (IC del 95 %, 0,04-0,13) y una diferencia de recurrencia del 33,5 % (IC del 95 %, 15,3 %-51,7 %). Los costes hospitalarios fueron mayores para la hemorroidectomía (1364 €; IC del 95 %, 895-1834; p < 0,001), al igual que los costes sociales (1984 €; IC del 95 %, -132-4101; p = 0,066). La razón costo-utilidad incremental para la hemorroidectomía fue de 24.042 € por AVAC ganado, y la razón costo-efectividad incremental fue de 5.918 € por recurrencia evitada. La probabilidad de que la hemorroidectomía sea costo-efectiva fue del 45,5% con 20.000 €/AVAC y del 83,9% con 50.000 €/AVAC. Para la prevención de la recurrencia, las probabilidades fueron del 98,3% y del 99,8%, respectivamente. LIMITACIONES: El pequeño tamaño de la muestra puede limitar la generalización y la capacidad de detectar complicaciones poco frecuentes pero costosas. Los costos del procedimiento se basaron en los precios hospitalarios promedio, lo cual constituye un enfoque pragmático, aunque menos detallado que el cálculo de costos ascendente. CONCLUSIONES: En pacientes con hemorroides de grado III, la hemorroidectomía ofrece mejores resultados clínicos a largo plazo, incluyendo una mayor calidad de vida y menores tasas de recurrencia en comparación con la ligadura con banda elástica. Sin embargo, su costo-efectividad varía en función de los umbrales de disposición a pagar de la sociedad. Se recomienda precaución antes de descartarla como tratamiento de primera línea basándose únicamente en los costos sanitarios o la disponibilidad limitada de quirófanos. (Traducción--Ingrid Melo)
- 26 March 2025
- Published by Wolters Kluwer Health in Diseases of the Colon & Rectum
- Vol. 68 (7) , e1090
Response to Letter to the Editor
An abstract is unavailable. This article is available as a PDF only.
- 26 March 2025
- Published by Wolters Kluwer Health in Diseases of the Colon & Rectum
- Vol. 68 (7) , e1090
Response to Letter to the Editor
An abstract is unavailable. This article is available as a PDF only.
- Open Access
- 14 February 2025
- Published by Wolters Kluwer Health in Diseases of the Colon & Rectum
- Vol. 68 (5) , 572-583
Comparison of Rubber Band Ligation and Hemorrhoidectomy in Patients With Symptomatic Hemorrhoids Grade III: A Multicenter, Open-Label, Randomized Controlled Noninferiority Trial
BACKGROUND: The optimal management strategy for grade III hemorrhoids remains a subject of ongoing debate. Hemorrhoidectomy is the criterion standard, but rubber band ligation offers a less invasive outpatient alternative. Treatment variability persists due to a lack of consensus on the preferred strategy. OBJECTIVE: To directly compare the effectiveness of rubber band ligation and hemorrhoidectomy in the treatment of grade III hemorrhoids. DESIGN: Open-label, parallel-group, randomized controlled noninferiority trial. SETTINGS: Multicenter study across 10 Dutch hospitals from October 2019 to September 2022. PATIENTS: Patients (aged 18 years or older) with symptomatic grade III (Goligher) hemorrhoids were included in this study. Exclusion criteria included prior rectal/anal surgery, more than 1 rubber band ligation/injection within the preceding 3 years, rectal radiation, preexisting sphincter injury, IBD, medical unfitness for surgery (ASA higher than 3), pregnancy, or hypercoagulability disorders. INTERVENTIONS: Randomized 1:1 to rubber band ligation or hemorrhoidectomy, with up to 2 banding sessions allowed. MAIN OUTCOME MEASURES: Primary outcomes included 12-month health-related quality of life and recurrence rate. Secondary outcomes included complications, pain, work resumption, and patient-reported outcome measures. RESULTS: Eighty-seven patients were randomly assigned (47 rubber band ligation vs 40 hemorrhoidectomy). Rubber band ligation was not noninferior to hemorrhoidectomy in quality-adjusted life years (–0.045; 95% CI, –0.087 to –0.004). Recurrence rate was worse in the rubber band ligation group (47.5% vs 6.1%), with an absolute risk difference of 41% (95% CI, 24%–59%). Complication rates were comparable. Pain scores after hemorrhoidectomy were higher during the first week (visual analogue scale 4 vs 1; p = 0.002). Rubber band ligation group returned to work sooner (1 vs 9 days; p = 0.021). Patient-reported hemorrhoidal symptom scores favored hemorrhoidectomy. LIMITATIONS: The primary limitation of the study was its early termination due to funding constraints, resulting in a relatively small sample size and limited statistical power. Patient recruitment was hindered by significant treatment preferences and the COVID-19 pandemic. CONCLUSIONS: Hemorrhoidectomy may benefit patients with grade III hemorrhoids in terms of quality of life, recurrence risk, and symptom burden, whereas rubber band ligation allows faster recovery with less pain. These findings can guide clinical decision-making. See Video Abstract. CLINICAL TRIAL REGISTRATION NUMBER: NCT04621695. COMPARACIÓN DE LA LIGADURA CON BANDA ELÁSTICA Y LA HEMORROIDECTOMÍA EN PACIENTES CON HEMORROIDES SINTOMÁTICAS GRADO III: ENSAYO MULTICÉNTRICO, ABIERTO, ALEATORIZADO, CONTROLADO Y DE NO INFERIORIDAD: ANTECEDENTES: La estrategia óptima de tratamiento para las hemorroides grado III sigue siendo un tema de debate continuo. La hemorroidectomía es el estándar de oro, pero la ligadura con banda elástica ofrece una alternativa ambulatoria menos invasiva. La variabilidad del tratamiento persiste debido a la falta de consenso sobre la estrategia preferida. OBJETIVO: Comparar directamente la eficacia de la ligadura con banda elástica y la hemorroidectomía en el tratamiento de las hemorroides grado III. DISEÑO: Ensayo de no inferioridad, controlado, aleatorizado, de grupos paralelos y abierto. ENTORNO CLINICO: Estudio multicéntrico en 10 hospitales holandeses desde octubre de 2019 hasta septiembre de 2022. PACIENTES: Pacientes (≥18 años) con hemorroides sintomáticas grado III (Goligher). Exclusiones: cirugía rectal/anal previa, >1 ligadura con banda elástica/inyección en los tres años anteriores, radiación rectal, lesión preexistente del esfínter, enfermedad inflamatoria intestinal, incapacidad médica para la cirugía (ASA >3), embarazo o trastornos de hipercoagulabilidad. INTERVENCIONES: Aleatorización 1:1 para ligadura con banda elástica o hemorroidectomía, con hasta dos sesiones de ligadura permitidas. PRINCIPALES MEDIDAS DE RESULTADOS: Primarias: calidad de vida relacionada con la salud a los 12 meses y tasa de recurrencia. Secundarias: complicaciones, dolor, reanudación del trabajo y medidas de resultados informadas por el paciente. RESULTADOS: Se aleatorizaron ochenta y siete pacientes (47 ligadura con banda elástica frente a 40 hemorroidectomía). La ligadura con banda elástica no fue no inferior a la hemorroidectomía en años de vida ajustados por calidad (-0,045, intervalo de confianza del 95 %: -0,087 a -0,004). La tasa de recurrencia fue peor en el grupo de ligadura con banda elástica (47,5 % frente a 6,1 %), con una diferencia de riesgo absoluto del 41 % (intervalo de confianza del 95 %: 24 %–59 %). Las tasas de complicaciones fueron comparables. Las puntuaciones de dolor posthemorroidectomía fueron más altas durante la primera semana (escala analógica visual 4 frente a 1; p = 0,002). El grupo de ligadura con banda elástica volvió al trabajo antes (1 frente a 9 días; p = 0,021). Las puntuaciones de síntomas hemorroidales notificadas por los pacientes favorecieron a la hemorroidectomía. LIMITACIONES: La principal limitación del estudio fue su finalización temprana debido a las limitaciones de financiación, lo que dio lugar a un tamaño de muestra relativamente pequeño y a un poder estadístico limitado. El reclutamiento de pacientes se vio obstaculizado por las preferencias significativas de tratamiento y la pandemia de COVID-19. CONCLUSIONES: La hemorroidectomía puede beneficiar a los pacientes con hemorroides de grado III en términos de calidad de vida, riesgo de recurrencia y carga de síntomas, mientras que la ligadura con banda elástica permite una recuperación más rápida con menos dolor. Estos hallazgos pueden orientar la toma de decisiones clínicas. (Traducción— Dr. Francisco M. Abarca-Rendon) NÚMERO DE REGISTRO DEL ENSAYO CLÍNICO: NCT04621695.
- 14 February 2025
- Published by Wolters Kluwer Health in Diseases of the Colon & Rectum
- Vol. 68 (5) , 572-583
Open AccessComparison of Rubber Band Ligation and Hemorrhoidectomy in Patients With Symptomatic Hemorrhoids Grade III: A Multicenter, Open-Label, Randomized Controlled Noninferiority Trial
BACKGROUND: The optimal management strategy for grade III hemorrhoids remains a subject of ongoing debate. Hemorrhoidectomy is the criterion standard, but rubber band ligation offers a less invasive outpatient alternative. Treatment variability persists due to a lack of consensus on the preferred strategy. OBJECTIVE: To directly compare the effectiveness of rubber band ligation and hemorrhoidectomy in the treatment of grade III hemorrhoids. DESIGN: Open-label, parallel-group, randomized controlled noninferiority trial. SETTINGS: Multicenter study across 10 Dutch hospitals from October 2019 to September 2022. PATIENTS: Patients (aged 18 years or older) with symptomatic grade III (Goligher) hemorrhoids were included in this study. Exclusion criteria included prior rectal/anal surgery, more than 1 rubber band ligation/injection within the preceding 3 years, rectal radiation, preexisting sphincter injury, IBD, medical unfitness for surgery (ASA higher than 3), pregnancy, or hypercoagulability disorders. INTERVENTIONS: Randomized 1:1 to rubber band ligation or hemorrhoidectomy, with up to 2 banding sessions allowed. MAIN OUTCOME MEASURES: Primary outcomes included 12-month health-related quality of life and recurrence rate. Secondary outcomes included complications, pain, work resumption, and patient-reported outcome measures. RESULTS: Eighty-seven patients were randomly assigned (47 rubber band ligation vs 40 hemorrhoidectomy). Rubber band ligation was not noninferior to hemorrhoidectomy in quality-adjusted life years (–0.045; 95% CI, –0.087 to –0.004). Recurrence rate was worse in the rubber band ligation group (47.5% vs 6.1%), with an absolute risk difference of 41% (95% CI, 24%–59%). Complication rates were comparable. Pain scores after hemorrhoidectomy were higher during the first week (visual analogue scale 4 vs 1; p = 0.002). Rubber band ligation group returned to work sooner (1 vs 9 days; p = 0.021). Patient-reported hemorrhoidal symptom scores favored hemorrhoidectomy. LIMITATIONS: The primary limitation of the study was its early termination due to funding constraints, resulting in a relatively small sample size and limited statistical power. Patient recruitment was hindered by significant treatment preferences and the COVID-19 pandemic. CONCLUSIONS: Hemorrhoidectomy may benefit patients with grade III hemorrhoids in terms of quality of life, recurrence risk, and symptom burden, whereas rubber band ligation allows faster recovery with less pain. These findings can guide clinical decision-making. See Video Abstract. CLINICAL TRIAL REGISTRATION NUMBER: NCT04621695. COMPARACIÓN DE LA LIGADURA CON BANDA ELÁSTICA Y LA HEMORROIDECTOMÍA EN PACIENTES CON HEMORROIDES SINTOMÁTICAS GRADO III: ENSAYO MULTICÉNTRICO, ABIERTO, ALEATORIZADO, CONTROLADO Y DE NO INFERIORIDAD: ANTECEDENTES: La estrategia óptima de tratamiento para las hemorroides grado III sigue siendo un tema de debate continuo. La hemorroidectomía es el estándar de oro, pero la ligadura con banda elástica ofrece una alternativa ambulatoria menos invasiva. La variabilidad del tratamiento persiste debido a la falta de consenso sobre la estrategia preferida. OBJETIVO: Comparar directamente la eficacia de la ligadura con banda elástica y la hemorroidectomía en el tratamiento de las hemorroides grado III. DISEÑO: Ensayo de no inferioridad, controlado, aleatorizado, de grupos paralelos y abierto. ENTORNO CLINICO: Estudio multicéntrico en 10 hospitales holandeses desde octubre de 2019 hasta septiembre de 2022. PACIENTES: Pacientes (≥18 años) con hemorroides sintomáticas grado III (Goligher). Exclusiones: cirugía rectal/anal previa, >1 ligadura con banda elástica/inyección en los tres años anteriores, radiación rectal, lesión preexistente del esfínter, enfermedad inflamatoria intestinal, incapacidad médica para la cirugía (ASA >3), embarazo o trastornos de hipercoagulabilidad. INTERVENCIONES: Aleatorización 1:1 para ligadura con banda elástica o hemorroidectomía, con hasta dos sesiones de ligadura permitidas. PRINCIPALES MEDIDAS DE RESULTADOS: Primarias: calidad de vida relacionada con la salud a los 12 meses y tasa de recurrencia. Secundarias: complicaciones, dolor, reanudación del trabajo y medidas de resultados informadas por el paciente. RESULTADOS: Se aleatorizaron ochenta y siete pacientes (47 ligadura con banda elástica frente a 40 hemorroidectomía). La ligadura con banda elástica no fue no inferior a la hemorroidectomía en años de vida ajustados por calidad (-0,045, intervalo de confianza del 95 %: -0,087 a -0,004). La tasa de recurrencia fue peor en el grupo de ligadura con banda elástica (47,5 % frente a 6,1 %), con una diferencia de riesgo absoluto del 41 % (intervalo de confianza del 95 %: 24 %–59 %). Las tasas de complicaciones fueron comparables. Las puntuaciones de dolor posthemorroidectomía fueron más altas durante la primera semana (escala analógica visual 4 frente a 1; p = 0,002). El grupo de ligadura con banda elástica volvió al trabajo antes (1 frente a 9 días; p = 0,021). Las puntuaciones de síntomas hemorroidales notificadas por los pacientes favorecieron a la hemorroidectomía. LIMITACIONES: La principal limitación del estudio fue su finalización temprana debido a las limitaciones de financiación, lo que dio lugar a un tamaño de muestra relativamente pequeño y a un poder estadístico limitado. El reclutamiento de pacientes se vio obstaculizado por las preferencias significativas de tratamiento y la pandemia de COVID-19. CONCLUSIONES: La hemorroidectomía puede beneficiar a los pacientes con hemorroides de grado III en términos de calidad de vida, riesgo de recurrencia y carga de síntomas, mientras que la ligadura con banda elástica permite una recuperación más rápida con menos dolor. Estos hallazgos pueden orientar la toma de decisiones clínicas. (Traducción— Dr. Francisco M. Abarca-Rendon) NÚMERO DE REGISTRO DEL ENSAYO CLÍNICO: NCT04621695.
- Open Access
- 31 May 2023
- Published by Wiley in Colorectal Disease
- Vol. 25 (8) , 1658-1670
Prospective cohort study of high‐volume transanal irrigation in patients with constipation and/or faecal incontinence
Aim: The aim of this work was to determine the clinical efficacy of high-volume transanal irrigation (TAI) in patients with constipation and/or faecal incontinence using validated symptom and quality of life questionnaires.Method: This was a prospective cohort study of 114 consecutive patients with constipation and/or faecal incontinence (Rome IV defined) who started TAI. A comprehensive questionnaire was completed at baseline and 4, 12, 26 and 52 weeks' follow-up. The primary objective was significant symptom reduction [>= 30%; Cleveland Clinic Constipation Score (CCCS) and St Marks Incontinence Score (SMIS)] in those who continued TAI at 52 weeks. Secondary objectives were (1) continuation rates of TAI, (2) effect on quality of life (QoL) and (3) identification of predictors for continuation.Results: A total of 59 (51.8%) patients with constipation, 26 (22.8%) with faecal incontinence and 29 (25.4%) with coexistent symptoms were included. At 52 weeks, 41 (36.0%) patients continued TAI, 63 (55.2%) stopped and 10 (8.8%) patients were lost to follow-up. In those who continued TAI at 52 weeks (n = 41), no reduction of constipation symptoms was observed. Median Patient Assessment of Constipation Quality of Life scores decreased on most domains, indicating QoL improvement. Reduction of faecal incontinence occurred in 5/9 (55.6%) patients with faecal incontinence and in 3/10 (30.0%) patients with coexistent symptoms. The median SMIS per-individual decreased in patients with coexistent symptoms (2; interquartile range 0-4; p = 0.023). Median Fecal Incontinence Quality of Life scores increased in most domains, indicating improved QoL. No clinical characteristics predicted continuation.Conclusion: One-third (n = 41) of patients continued TAI at 52 weeks. In those who continued TAI at 52 weeks, symptoms of faecal incontinence (SMIS) were reduced but not constipation (CCCS). QoL related to both constipation and faecal incontinence improved. No clinical characteristics predicted continuation.
- 31 May 2023
- Published by Wiley in Colorectal Disease
- Vol. 25 (8) , 1658-1670
Open AccessProspective cohort study of high‐volume transanal irrigation in patients with constipation and/or faecal incontinence
Aim: The aim of this work was to determine the clinical efficacy of high-volume transanal irrigation (TAI) in patients with constipation and/or faecal incontinence using validated symptom and quality of life questionnaires.Method: This was a prospective cohort study of 114 consecutive patients with constipation and/or faecal incontinence (Rome IV defined) who started TAI. A comprehensive questionnaire was completed at baseline and 4, 12, 26 and 52 weeks' follow-up. The primary objective was significant symptom reduction [>= 30%; Cleveland Clinic Constipation Score (CCCS) and St Marks Incontinence Score (SMIS)] in those who continued TAI at 52 weeks. Secondary objectives were (1) continuation rates of TAI, (2) effect on quality of life (QoL) and (3) identification of predictors for continuation.Results: A total of 59 (51.8%) patients with constipation, 26 (22.8%) with faecal incontinence and 29 (25.4%) with coexistent symptoms were included. At 52 weeks, 41 (36.0%) patients continued TAI, 63 (55.2%) stopped and 10 (8.8%) patients were lost to follow-up. In those who continued TAI at 52 weeks (n = 41), no reduction of constipation symptoms was observed. Median Patient Assessment of Constipation Quality of Life scores decreased on most domains, indicating QoL improvement. Reduction of faecal incontinence occurred in 5/9 (55.6%) patients with faecal incontinence and in 3/10 (30.0%) patients with coexistent symptoms. The median SMIS per-individual decreased in patients with coexistent symptoms (2; interquartile range 0-4; p = 0.023). Median Fecal Incontinence Quality of Life scores increased in most domains, indicating improved QoL. No clinical characteristics predicted continuation.Conclusion: One-third (n = 41) of patients continued TAI at 52 weeks. In those who continued TAI at 52 weeks, symptoms of faecal incontinence (SMIS) were reduced but not constipation (CCCS). QoL related to both constipation and faecal incontinence improved. No clinical characteristics predicted continuation.
- Open Access
- 16 January 2023
- Published by Springer Nature in International Journal of Colorectal Disease
- Vol. 38 (1) , 1-12
To what extent are anorectal function tests comparable? A study comparing digital rectal examination, anal electromyography, 3-dimensional high-resolution anal manometry, and transperineal ultrasound
Background: Anorectal function tests are helpful for objective investigation of anorectal (dys)function. A variety of tests are available, but there is no recommendation when to perform which test. Furthermore, which test is the most accurate is controversial and the correlation between these tests is not very clear. The aim of our study was to examine the correlation of anal pressures and the possibility to diagnose pelvic floor dyssynergia between digital rectal examination (DRE) and several anorectal function tests. Methods: Between January 2020 and April 2022, all men and women aged 18 to 80 years, treated at the Proctos Clinic, who were referred for pelvic floor physical therapy (PFPT) by the surgeon and underwent anorectal function tests, were included. DRE was performed to establish the anal pressure at rest and during squeeze and straining. Anorectal function tests included 3D high-resolution anal manometry (3D-HRAM), balloon expulsion test (BET), transperineal ultrasound (TPUS), and surface electromyography (s-EMG). Results: A total of 50 patients, 37 (74%) females, were included. Median age was 51 years. Twenty-three (62%) females had a history of two or more vaginal deliveries. The most frequent reason for referral for PFPT was fecal incontinence in 27 (54%) patients. The assessed pressures and pelvic floor function measured with DRE by the surgeon and the pelvic floor physical therapist during rest, squeeze, and straining correlated in 78%, 78%, and 84%, respectively. Correlation between DRE and 3D-HRAM or s-EMG was better for squeeze pressures than resting pressures. The correlation between s-EMG and 3D-HRAM was better during squeeze than at rest with an agreement of 59% and 37%, respectively. Conclusion: DRE by an experienced investigator is of sufficient value for daily clinical practice to detect dyssynergia and to measure sphincter tone. Commonly performed anorectal function tests correlate poorly with DRE and with other anorectal function tests. When conservative treatment fails, further investigation is warranted; however, these results should be interpreted with caution. What does this paper add to the literature?: Anorectal function tests such as the 3D high-resolution anorectal manometry, balloon expulsion test, surface electromyography, and transperineal ultrasound are all frequently performed in the diagnostic workup in patients with defecation disorders. No previous study has compared these tests regarding their outcomes, nor has the interrater agreement been measured regarding the digital rectal examination by two experienced observers. Furthermore, transperineal ultrasound is in all probability not frequently used and therefore underexposed in the diagnostic workup of patients with dyssynergic defecation.
- 16 January 2023
- Published by Springer Nature in International Journal of Colorectal Disease
- Vol. 38 (1) , 1-12
Open AccessTo what extent are anorectal function tests comparable? A study comparing digital rectal examination, anal electromyography, 3-dimensional high-resolution anal manometry, and transperineal ultrasound
Background: Anorectal function tests are helpful for objective investigation of anorectal (dys)function. A variety of tests are available, but there is no recommendation when to perform which test. Furthermore, which test is the most accurate is controversial and the correlation between these tests is not very clear. The aim of our study was to examine the correlation of anal pressures and the possibility to diagnose pelvic floor dyssynergia between digital rectal examination (DRE) and several anorectal function tests. Methods: Between January 2020 and April 2022, all men and women aged 18 to 80 years, treated at the Proctos Clinic, who were referred for pelvic floor physical therapy (PFPT) by the surgeon and underwent anorectal function tests, were included. DRE was performed to establish the anal pressure at rest and during squeeze and straining. Anorectal function tests included 3D high-resolution anal manometry (3D-HRAM), balloon expulsion test (BET), transperineal ultrasound (TPUS), and surface electromyography (s-EMG). Results: A total of 50 patients, 37 (74%) females, were included. Median age was 51 years. Twenty-three (62%) females had a history of two or more vaginal deliveries. The most frequent reason for referral for PFPT was fecal incontinence in 27 (54%) patients. The assessed pressures and pelvic floor function measured with DRE by the surgeon and the pelvic floor physical therapist during rest, squeeze, and straining correlated in 78%, 78%, and 84%, respectively. Correlation between DRE and 3D-HRAM or s-EMG was better for squeeze pressures than resting pressures. The correlation between s-EMG and 3D-HRAM was better during squeeze than at rest with an agreement of 59% and 37%, respectively. Conclusion: DRE by an experienced investigator is of sufficient value for daily clinical practice to detect dyssynergia and to measure sphincter tone. Commonly performed anorectal function tests correlate poorly with DRE and with other anorectal function tests. When conservative treatment fails, further investigation is warranted; however, these results should be interpreted with caution. What does this paper add to the literature?: Anorectal function tests such as the 3D high-resolution anorectal manometry, balloon expulsion test, surface electromyography, and transperineal ultrasound are all frequently performed in the diagnostic workup in patients with defecation disorders. No previous study has compared these tests regarding their outcomes, nor has the interrater agreement been measured regarding the digital rectal examination by two experienced observers. Furthermore, transperineal ultrasound is in all probability not frequently used and therefore underexposed in the diagnostic workup of patients with dyssynergic defecation.
- Open Access
Antibiotic Treatment foLlowing surgical drAinage of perianal abScess (ATLAS): protocol for a multicentre, double-blind, placebo-controlled, randomised trial
Introduction Perianal fistula is a burdening disease with an annual incidence of 6–12/100 000 in Western countries. More than 90% of crypto-glandular fistulas originate from perianal abscess. Despite adequate drainage, up to 83% recur or result in an anal fistula, the majority developing within 12 months. There is some evidence that gut-derived bacteria play a role in the development of perianal fistula. Up till now, it is not common practice to routinely administer prophylactic antibiotics to prevent anal fistula development. There is a need for a study to establish whether adding antibiotic treatment to surgical drainage of perianal abscess results in a reduction in perianal fistulas. Methods and analysis This multicentre, double-blind, randomised, placebo-controlled trial investigates whether addition of antibiotics (ciprofloxacin and metronidazole) to surgical drainage of a perianal abscess is beneficial compared with surgical drainage alone. The primary outcome is the development of a perianal fistula within 1 year. Secondary outcomes include quality of life, treatment costs, need for repeated drainage, patient-reported outcomes and other clinical outcomes. Participants are recruited in one academic and seven peripheral Dutch clinics. To demonstrate a reduction of perianal fistula from 30% to 15% when treated with adjuvant antibiotics with a two-sided alpha of 0.05, a power of 80% and taking a 10% loss to follow-up percentage into account, the total sample size will be 298 participants. Data will be analysed according to the intention-to-treat principle. Ethics and dissemination The study protocol has been approved by the Medical Ethics Review Committee of the Amsterdam University Medical Centers (nr. 2021_010). Written consent is obtained from each participant prior to randomisation into the study. The results of this trial will be submitted for publication in international peer-reviewed journals, presented at conferences and spread to coloproctological associations. Trial registration numbers 2020-004449-35; NCT05385887.
Open AccessAntibiotic Treatment foLlowing surgical drAinage of perianal abScess (ATLAS): protocol for a multicentre, double-blind, placebo-controlled, randomised trial
Introduction Perianal fistula is a burdening disease with an annual incidence of 6–12/100 000 in Western countries. More than 90% of crypto-glandular fistulas originate from perianal abscess. Despite adequate drainage, up to 83% recur or result in an anal fistula, the majority developing within 12 months. There is some evidence that gut-derived bacteria play a role in the development of perianal fistula. Up till now, it is not common practice to routinely administer prophylactic antibiotics to prevent anal fistula development. There is a need for a study to establish whether adding antibiotic treatment to surgical drainage of perianal abscess results in a reduction in perianal fistulas. Methods and analysis This multicentre, double-blind, randomised, placebo-controlled trial investigates whether addition of antibiotics (ciprofloxacin and metronidazole) to surgical drainage of a perianal abscess is beneficial compared with surgical drainage alone. The primary outcome is the development of a perianal fistula within 1 year. Secondary outcomes include quality of life, treatment costs, need for repeated drainage, patient-reported outcomes and other clinical outcomes. Participants are recruited in one academic and seven peripheral Dutch clinics. To demonstrate a reduction of perianal fistula from 30% to 15% when treated with adjuvant antibiotics with a two-sided alpha of 0.05, a power of 80% and taking a 10% loss to follow-up percentage into account, the total sample size will be 298 participants. Data will be analysed according to the intention-to-treat principle. Ethics and dissemination The study protocol has been approved by the Medical Ethics Review Committee of the Amsterdam University Medical Centers (nr. 2021_010). Written consent is obtained from each participant prior to randomisation into the study. The results of this trial will be submitted for publication in international peer-reviewed journals, presented at conferences and spread to coloproctological associations. Trial registration numbers 2020-004449-35; NCT05385887.
- Open Access
- 30 April 2022
- Published by Korean Society of Coloproctology in Annals of Coloproctology
- Vol. 38 (2) , 146-152
Hemorrhoidectomy versus rubber band ligation in grade III hemorrhoidal disease: a large retrospective cohort study with long-term follow-up
Purpose: Standard therapy for grade III hemorrhoids is rubber band ligation (RBL) and hemorrhoidectomy. The long-term clinical and patient-reported outcomes of these treatments in a tertiary referral center for proctology were evaluated.Methods: A retrospective analysis was performed in all patients with grade III hemorrhoids who were treated between January 2013 and August 2018. Medical history, symptoms, reinterventions, complications, and patient-reported outcome measurements (PROM) were retrieved from individual electronic patient files, which were prospectively entered as standard questionnaires in our clinic.Results: Overall, 327 patients (163 males) were treated by either RBL (n=182) or hemorrhoidectomy (n=145). The median follow-up was 44 months. The severity of symptoms and patient preference led to the treatment of choice. The most commonly experienced symptoms were prolapse (83.2%) and blood loss (69.7%). Hemorrhoidectomy was effective in 95.9% of the cases as a single procedure, while a single RBL procedure was only effective in 51.6%. In the RBL group, 34.6% received a second RBL session. Complications were not significantly different, 11 (7.6%) after hemorrhoidectomy versus 6 (3.3%) after RBL. However, 4 fistulas developed after hemorrhoidectomy and none after RBL (P<0.05). The pre-procedure PROM score was higher in the hemorrhoidectomy group whereas the post-procedure PROM score did not significantly differ between the groups.Conclusion: Treatment of grade III hemorrhoids usually requires more than one session RBL whereas 1-time hemorrhoidectomy suffices. Complications were more common after hemorrhoidectomy. The patient-related outcome did not differ between procedures.
- 30 April 2022
- Published by Korean Society of Coloproctology in Annals of Coloproctology
- Vol. 38 (2) , 146-152
Open AccessHemorrhoidectomy versus rubber band ligation in grade III hemorrhoidal disease: a large retrospective cohort study with long-term follow-up
Purpose: Standard therapy for grade III hemorrhoids is rubber band ligation (RBL) and hemorrhoidectomy. The long-term clinical and patient-reported outcomes of these treatments in a tertiary referral center for proctology were evaluated.Methods: A retrospective analysis was performed in all patients with grade III hemorrhoids who were treated between January 2013 and August 2018. Medical history, symptoms, reinterventions, complications, and patient-reported outcome measurements (PROM) were retrieved from individual electronic patient files, which were prospectively entered as standard questionnaires in our clinic.Results: Overall, 327 patients (163 males) were treated by either RBL (n=182) or hemorrhoidectomy (n=145). The median follow-up was 44 months. The severity of symptoms and patient preference led to the treatment of choice. The most commonly experienced symptoms were prolapse (83.2%) and blood loss (69.7%). Hemorrhoidectomy was effective in 95.9% of the cases as a single procedure, while a single RBL procedure was only effective in 51.6%. In the RBL group, 34.6% received a second RBL session. Complications were not significantly different, 11 (7.6%) after hemorrhoidectomy versus 6 (3.3%) after RBL. However, 4 fistulas developed after hemorrhoidectomy and none after RBL (P<0.05). The pre-procedure PROM score was higher in the hemorrhoidectomy group whereas the post-procedure PROM score did not significantly differ between the groups.Conclusion: Treatment of grade III hemorrhoids usually requires more than one session RBL whereas 1-time hemorrhoidectomy suffices. Complications were more common after hemorrhoidectomy. The patient-related outcome did not differ between procedures.
- Open Access
- 9 February 2022
- Published by Springer Nature in Techniques in Coloproctology
- Vol. 26 (5) , 387-392
Is the Goligher classification a valid tool in clinical practice and research for hemorrhoidal disease?
Background: The most widely used classification for hemorrhoidal disease (HD) is the Goligher classification, which ranks presence and severity of prolapse in four grades. Since physicians base this gradation on medical history and physical examination, it might be prone to interobserver variability. Furthermore, the gradation impacts the treatment of choice which makes reproducibility of utmost importance. The aim of this study was to determine the interobserver variability of Goligher classification among surgeons in the Netherlands. Methods: A single-choice survey was used. The first part consisted of questions concerning baseline characteristics and the use of the Goligher classification in routine clinical practice. In the second part, to assess interobserver variability, we asked gastrointestinal surgeons and residents who routinely treat HD to review 25 photographs (with given timing as during rest or push) of patients with HD and classify the gradation using the Goligher classification. The survey was sent by email on April 19, 2021 and was available online until July 5, 2021. Interobserver variability was assessed using Fleiss’ Kappa test. Results: A total of 329 gastrointestinal surgeons, fellows and residents were sent an invitation email, of whom 95 (29%) completed the survey. Among the respondents, 87% indicated that they use the Goligher classification in clinical practice. Eighty-one percent found the classification helpful and 63% classified HD according to Goligher and followed the guidelines for treatment of HD accordingly. The interobserver variability showed an overall fair strength of agreement, with a Fleiss’ Kappa (κ) of 0.376 (95% CI 0.373–0.380). There was a moderate agreement for grade I and IV HD with a κ statistic of 0.466 and 0.522, respectively. For grades II and III, there was a lower (fair) strength of agreement with 0.206 and 0.378, respectively. Conclusions: The fair interobserver variability is disappointing and demonstrates the need for a more reliable, and internationally accepted, classification for HD. A new classification should enable more uniformity in treating HD and in comparing outcomes of future trials and prospective registries. The protocol for a Delphi study for a new classification system is currently being prepared and led by an international research group.
- 9 February 2022
- Published by Springer Nature in Techniques in Coloproctology
- Vol. 26 (5) , 387-392
Open AccessIs the Goligher classification a valid tool in clinical practice and research for hemorrhoidal disease?
Background: The most widely used classification for hemorrhoidal disease (HD) is the Goligher classification, which ranks presence and severity of prolapse in four grades. Since physicians base this gradation on medical history and physical examination, it might be prone to interobserver variability. Furthermore, the gradation impacts the treatment of choice which makes reproducibility of utmost importance. The aim of this study was to determine the interobserver variability of Goligher classification among surgeons in the Netherlands. Methods: A single-choice survey was used. The first part consisted of questions concerning baseline characteristics and the use of the Goligher classification in routine clinical practice. In the second part, to assess interobserver variability, we asked gastrointestinal surgeons and residents who routinely treat HD to review 25 photographs (with given timing as during rest or push) of patients with HD and classify the gradation using the Goligher classification. The survey was sent by email on April 19, 2021 and was available online until July 5, 2021. Interobserver variability was assessed using Fleiss’ Kappa test. Results: A total of 329 gastrointestinal surgeons, fellows and residents were sent an invitation email, of whom 95 (29%) completed the survey. Among the respondents, 87% indicated that they use the Goligher classification in clinical practice. Eighty-one percent found the classification helpful and 63% classified HD according to Goligher and followed the guidelines for treatment of HD accordingly. The interobserver variability showed an overall fair strength of agreement, with a Fleiss’ Kappa (κ) of 0.376 (95% CI 0.373–0.380). There was a moderate agreement for grade I and IV HD with a κ statistic of 0.466 and 0.522, respectively. For grades II and III, there was a lower (fair) strength of agreement with 0.206 and 0.378, respectively. Conclusions: The fair interobserver variability is disappointing and demonstrates the need for a more reliable, and internationally accepted, classification for HD. A new classification should enable more uniformity in treating HD and in comparing outcomes of future trials and prospective registries. The protocol for a Delphi study for a new classification system is currently being prepared and led by an international research group.
- Open Access
- 15 April 2021
- Published by Springer Nature in Techniques in Coloproctology
- Vol. 25 (6) , 709-719
Management of cryptoglandular fistula-in-ano among gastrointestinal surgeons in the Netherlands
Background: Management of cryptoglandular fistula-in-ano (FIA) can be challenging. Despite Dutch and international guidelines determining optimal therapy is still quite difficult. The aim of this study was to report current practices in the management of cryptoglandular FIA among gastrointestinal surgeons in the Netherlands. Methods: Dutch surgeons and residents who are treating FIA regularly were sent a survey invitation by email. The survey was available online from September 19 to December 1 2019. The questionnaire consisted of 28 questions concerning diagnostic and surgical techniques in the treatment of intersphincteric and transsphincteric FIA. Results: In total, 147 (43%) surgeons responded and completed the survey. Magnetic resonance imaging was the preferred diagnostic imaging modality (97%) followed by the endo-anal ultrasound (12%). In case of a high FIA, 86% used a non-cutting seton. Most respondents removed a seton between 6 weeks and 3 months (n = 84, 58%). Fistulotomy was the procedure of preference in low transsphincteric (86%) and low intersphincteric FIA (92%). Mucosal advancement flap (MAF) and ligation of intersphincteric fistula tract (LIFT), with 78% and 46%, respectively, were the procedures that were applied most often in high transsphincteric FIA. In high intersphincteric FIA 67% performed a MAF and 33% a fistulotomy. Thirty-three percent of all respondents stated that they habitually closed the internal fistula opening, half of them used a Z-plasty. For debridement of the fistula tract the preferred method was curettage (78%). Conclusions: Dutch gastrointestinal surgeons use various techniques in the management of FIA. Novel promising techniques should be investigated adequately in sufficient large trials to increase consensus. A core outcome measurement and a prospective international database would help in comparing results. Until then, treatment should be adjusted to the individual patient, governed by fistula characteristics and patient choice.
- 15 April 2021
- Published by Springer Nature in Techniques in Coloproctology
- Vol. 25 (6) , 709-719
Open AccessManagement of cryptoglandular fistula-in-ano among gastrointestinal surgeons in the Netherlands
Background: Management of cryptoglandular fistula-in-ano (FIA) can be challenging. Despite Dutch and international guidelines determining optimal therapy is still quite difficult. The aim of this study was to report current practices in the management of cryptoglandular FIA among gastrointestinal surgeons in the Netherlands. Methods: Dutch surgeons and residents who are treating FIA regularly were sent a survey invitation by email. The survey was available online from September 19 to December 1 2019. The questionnaire consisted of 28 questions concerning diagnostic and surgical techniques in the treatment of intersphincteric and transsphincteric FIA. Results: In total, 147 (43%) surgeons responded and completed the survey. Magnetic resonance imaging was the preferred diagnostic imaging modality (97%) followed by the endo-anal ultrasound (12%). In case of a high FIA, 86% used a non-cutting seton. Most respondents removed a seton between 6 weeks and 3 months (n = 84, 58%). Fistulotomy was the procedure of preference in low transsphincteric (86%) and low intersphincteric FIA (92%). Mucosal advancement flap (MAF) and ligation of intersphincteric fistula tract (LIFT), with 78% and 46%, respectively, were the procedures that were applied most often in high transsphincteric FIA. In high intersphincteric FIA 67% performed a MAF and 33% a fistulotomy. Thirty-three percent of all respondents stated that they habitually closed the internal fistula opening, half of them used a Z-plasty. For debridement of the fistula tract the preferred method was curettage (78%). Conclusions: Dutch gastrointestinal surgeons use various techniques in the management of FIA. Novel promising techniques should be investigated adequately in sufficient large trials to increase consensus. A core outcome measurement and a prospective international database would help in comparing results. Until then, treatment should be adjusted to the individual patient, governed by fistula characteristics and patient choice.